THEMIS MEDICARE
Back to Balance Sheet
|
THEMIS MEDICARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹34 Cr | ₹35 Cr | ₹31 Cr | ₹24 Cr | ₹7.51 Cr |
What is the latest Total Non-Current Liabilities ratio of THEMIS MEDICARE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹34 Cr |
Mar2023 | ₹35 Cr |
Mar2022 | ₹31 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹7.51 Cr |
How is Total Non-Current Liabilities of THEMIS MEDICARE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹34 Cr | -3.44 | |
Mar2023 | ₹35 Cr | 14.99 | |
Mar2022 | ₹31 Cr | 26.50 | |
Mar2021 | ₹24 Cr | 224.07 | |
Mar2020 | ₹7.51 Cr | - |
Compare Total Non-Current Liabilities of peers of THEMIS MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THEMIS MEDICARE | ₹1,148.2 Cr | -0.2% | -9.4% | -45.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
THEMIS MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THEMIS MEDICARE | -0.2% |
-9.4% |
-45.4% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses